carbohydr
content
coronaviru
glycoprotein
el
analyz
complex
mannoserichtyp
oligosaccharid
sidechain
attach
nglycosid
linkag
polypeptid
glycosyl
initi
cotransl
level
inhibit
tunicamycin
thu
belong
glycoprotein
type
found
mani
envelop
virus
el
contrast
repres
differ
class
glycoprotein
follow
observ
indic
carbohydr
sidechain
oglycosidir
linkag
constitu
sugar
el
vacrtylglucosamin
nacet
ylgalactosamin
galactos
neuramin
acid
mannos
fucos
absent
sidechain
remov
elimin
glycosyl
el
sensit
compound
interf
vglycosyl
el
first
viral
glycoprotein
analyz
contain
oglycosid
linkag
coronavirus
therefor
suitabl
model
system
studi
biosynthesi
process
type
glycoprotein
q
academ
press
inc
london
ltd
coronavirus
group
posit
strand
rnacontain
virus
caus
respiratori
gastroenter
central
nervou
disord
human
anim
mcintosh
tyrrel
et
ae
robb
bond
nagashima
et
nagashima
et
gerd
et
al
report
serolog
crossreact
virus
isol
multipl
sclerosi
patient
mous
hepat
viru
prototyp
coronaviru
character
detail
molecular
level
contain
three
structur
protein
nucleocapsid
protein
n
jz
phosphoryl
stohlman
lai
two
envelop
glycoprotein
el
glycoprotein
el
probabl
transmembran
matrix
protein
carbohydr
moieti
resid
outsid
viru
particl
sturman
appear
matur
virion
two
form
constitut
clubshap
peplom
protrud
viral
membran
surround
particl
like
corona
treatment
purifi
viru
trypsin
vitro
speci
convert
int
ooo
cleavag
product
sturman
holm
glycosyl
viral
glycoprotein
studi
detail
sever
envelop
virus
includ
alpha
rhabdoand
myxovirus
review
see
klenk
rott
virus
share
common
pathway
glycosyl
cotranslat
ional
event
nascent
polypeptid
chain
extend
lumen
rough
endoplasm
ret
iculum
glycosyl
transfer
en
bloc
activ
oligosaccharid
dolichollink
intermedi
dalpp
glcnac
struck
lennarz
initi
step
requir
tripeptid
sequenc
h
kasnxser
thr
cooh
peptid
chain
result
carbohydr
protein
linkag
nglycosid
type
nacetylglucosamin
asparagin
way
plasma
membran
core
oligosaccharid
trim
new
sugar
includ
galactos
fucos
neuramin
acid
ad
golgi
apparatu
organel
viral
glycoprotein
transport
plasma
membran
sequest
bud
viru
particl
report
glycoprotein
el
roronavirus
follow
gener
accept
glycosyl
pathway
show
glycosyl
el
posttransl
event
inhibit
tunicamycin
glycosyl
inhibitor
interfer
format
mglycosid
linkag
constitu
analysi
carbohydr
sidechain
el
well
sensit
mild
alkalin
treatment
suggest
oglycosid
type
linkag
oligosaccharid
polypeptid
describ
viral
structur
protein
lirus
wnd
cell
mous
hepat
viru
mhv
host
cell
line
clone
line
spontan
transform
cell
obtain
dr
l
sturman
albani
ny
bovin
coronaviru
lq
grown
primari
bovin
fetal
hyroid
cell
describ
storz
et
al
viru
purifi
accord
sturman
et
al
viru
titer
determin
plaqu
assay
wv
agar
overlay
medium
b
label
viral
polypeptid
obtain
radioact
viru
particl
glucosamin
cimmol
amershambuchl
braunschweig
frg
galactos
cimmol
fucos
cimmol
mannos
cimmol
ad
growth
medium
final
concentr
pciml
h
adsorpt
period
viru
protein
hydrolys
mcimatom
use
iml
n
palmit
acid
use
iml
schmidt
schlesing
analyz
intracellular
synthesi
viral
polypeptid
monolay
cell
cm
petri
dish
infect
multipl
infect
plaqueform
unitscel
h
post
infect
medium
replac
medium
without
leucin
h
leucin
starvat
cell
pulselabel
min
addit
h
leucineml
either
lyse
directli
immunoprecipit
chase
medium
contain
unlabel
leucin
time
indic
experi
tunicamycin
use
antibiot
pgml
eli
lilli
indianapoli
ad
begin
starvat
period
present
throughout
rest
experi
purifi
viru
x
pfut
emulsifi
complet
freund
adjuv
inject
intraderm
new
zealand
white
rabbit
five
week
later
rabbit
boost
subcutan
inject
viru
suspens
pfu
salin
one
week
later
rabbit
bled
viru
neutral
titer
serum
determin
plaqu
inhibit
test
serum
titer
reduct
plaqu
immunoprecipit
serum
purifi
host
cellspecif
antibodi
passag
sepharos
column
cell
extract
noninfect
rell
coval
coupl
immunoprecipit
label
cell
lyse
ripa
buffer
mlcrtri
hcl
ph
rnmedta
lo
vv
triton
l
wv
sodium
deoxychol
old
wv
sd
vv
trasylol
bayer
ag
germani
clarifi
centrifug
g
min
supernat
incub
min
ice
rabbit
antiserum
immun
complex
adsorb
suspens
protein
abear
staphyloccu
aureu
kessler
ripa
buffer
contain
vv
fetal
calf
serum
mixtur
vash
time
wash
buffer
mmsodium
phosphat
ph
mwedta
mivacl
l
b
vv
triton
vv
trasylol
final
pellet
resuspend
sampl
buffer
subject
ed
electrophoresi
describ
e
polyacrylamid
gel
electrophoresi
isolatiorl
viral
glycopeptid
wv
polyacrylamid
gradient
slab
gel
contain
lo
wv
sd
murea
use
laemmli
sampl
heat
min
mmtri
hcl
ph
vv
glycerol
wv
sd
vv
resolv
radiolabel
protein
band
local
fluorographi
laskey
mill
use
kodak
film
prepar
isol
viral
glycoprotein
cylindr
lo
polpacrylamid
gel
mm
x
mm
use
slice
radioact
sister
gel
determin
liquid
scintil
count
schwarz
klenk
viral
glycoprotein
recov
freez
thaw
elut
wit
h
lo
wv
sd
water
filtrat
pm
millipor
filter
unit
repeat
precipit
vv
aqueou
aceton
prepar
dialyz
distil
water
lyophil
radiolabel
glycopeptid
obtain
digest
wv
pronasr
io
c
mtri
hcl
ph
mcacl
h
second
addit
pronas
h
insolubl
materi
remov
centrifug
supernat
extract
chloroformmethanol
vv
upper
phase
contain
essenti
radiolabel
lyophil
desalt
biogel
column
cm
x
cm
fraction
el
glycopeptid
obtain
affin
chromatographi
column
lcm
x
cm
wheat
germ
agglutininsepharos
pharmacia
desalt
glgropeptld
appli
lsodium
acet
buffer
ph
column
eyuilibr
buffer
column
wash
buffer
adsorb
materi
elut
buffer
contain
msacetylglucosamin
unbound
bound
fraction
desalt
freed
vacetylglucosamin
bj
chromatographi
biogel
describ
use
distil
water
eluent
bind
studi
glycopeptid
concanavalin
asepharos
pharmacia
perform
describrd
b
v
krusiu
finn
f
digest
glycxxidas
glycopeptid
treat
unit
neuraminidas
vibrio
cholerup
behringwerk
ml
mmtrisacet
ph
mmc
l
h
incub
mixtur
appli
biogel
column
cm
x
cm
elut
mpyridin
acet
ph
escherichia
freundii
kind
gift
dr
n
fukuda
seattl
el
glycopeptid
incub
milliunit
enzym
ml
msodium
acet
ph
h
sampl
analyz
column
biogel
minu
mesh
cm
x
cm
endo
nacetylglucosaminidas
h
streptomyc
griseu
purchas
seikagaku
kogyo
japan
glycopeptid
incub
milliunit
enzym
ml
mcitratephosph
buffer
ph
incub
h
toluen
atmospher
enzymetr
glycopeptid
analyz
biogel
minu
mesh
column
describ
g
alkali
borohydrid
treatmenf
analysi
amino
acid
radiolabel
glycoprotein
e
iw
subject
pelimin
condit
accord
pigman
down
use
porcin
submaxillari
gland
protein
control
amino
acid
analys
perform
biotron
lcbooo
amino
acid
analyz
describ
spackman
et
al
prepar
reduc
oligosaccharid
method
carlson
appli
follow
modif
sampl
kept
h
ivnaoh
contain
mnabh
wv
sd
cool
ph
mixtur
adjust
addit
maqueou
acet
acid
sampl
psssed
dowex
wx
mesh
h
form
serva
column
cm
x
cm
wash
l
vv
acet
acid
elut
materi
lyophil
boric
acid
remov
repeat
evapor
methanol
highvoltag
paper
electrophoresi
releas
oligosaccharid
conduct
whatman
paper
pyridineacet
acidwat
vol
ph
vcm
h
paper
cut
cm
strip
radioact
determin
liquid
scintil
count
ing
molecular
weight
releas
oligosaccharid
determin
calibr
biogel
minu
mesh
batch
column
cm
x
cm
mpyridin
acet
ph
fraction
ml
taken
assay
radioact
liquid
scintil
count
h
carbohydratr
mcxstituent
analysi
reagent
ultrapur
grade
freshli
distil
desalt
glycopeptid
contain
pg
total
sugar
hydrolyz
mh
vv
aqueou
acet
acid
h
reduc
peracetyl
describ
stellner
hakomori
peracetyl
alditol
acet
analyz
finnigan
model
combin
ga
chromatographmass
spectromet
use
fuse
silica
capillari
column
dexsil
wall
coat
phase
sugar
ratio
calcul
basi
total
reconstruct
ion
chromatogram
appli
respons
factor
hat
determin
correspond
commerci
standard
paper
chromatographi
hydrolys
carri
whatman
paper
sheet
descend
manner
use
ethyl
acetatepyridinewat
vol
solvent
analysi
radiolabel
mous
hepat
viru
protein
mhv
grown
presenc
sugar
protein
hydrolys
purifi
viru
prepar
analyz
sdspolyacrylamid
gel
electrophoresi
fig
fin
incorporat
ion
radioactiw
amino
acid
sugar
coronaviru
polypeptid
coronaviru
grown
clone
line
spontan
transform
cell
presenc
radioact
marker
indic
viru
harvest
h
post
infect
purifi
analyz
cylindr
sdscontain
loo
b
wv
polyacrylamid
gel
gel
slice
radioact
resolv
polypeptid
indic
determin
liquid
scint
illat
count
fig
l
periph
spike
glycoprotein
proteolyt
j
cleavag
product
poorli
label
probabl
due
partial
loss
spike
peplom
viru
purif
common
observ
coronavirus
analqrsi
mhv
label
radioact
sugar
iglucosamin
galactos
fucos
lmannos
show
sugar
present
unexpect
sinc
carbohydr
pattern
found
mani
viral
glycoprotein
el
howev
label
either
fucos
mannos
fig
l
e
absenc
mannos
signific
sinc
mannos
essenti
constitu
carbohydrat
e
core
structur
nglycosid
link
sidechain
radioact
band
figur
b
c
migrat
faster
glycoprotein
el
probabl
glycolipid
suggest
observ
materi
label
amino
acid
mannos
fucos
remov
gel
fixat
organ
solvent
isobutanol
fig
order
investig
whether
presenc
fl
abnorm
label
characterist
uniqu
murin
coronaviru
gener
coronavirusspecif
phenomenon
also
analyz
glycosylat
ion
pattern
enteropathogen
bovin
coronaviru
grown
primari
bovin
fetal
thyroid
cell
storz
et
al
fig
low
molecular
weight
glycoprotein
comigr
murin
el
sdspolyacrylamid
gel
electrophoresi
present
bovin
viru
prepar
polypeptid
readili
aggreg
materi
high
molecular
weight
boil
presenc
reduc
agent
data
shown
glycoprotein
el
murin
viru
sturman
metabol
label
indic
el
bovin
viru
could
label
galactos
glucosamin
fucos
mannos
b
label
h
palmit
acid
order
investig
whether
glycoprotein
el
purifi
prepar
polyacrylamid
gel
electrophoresi
possibl
contamin
tightli
bound
glycolipid
analyz
viru
grown
presenc
palmit
acid
figur
show
el
label
condit
thu
glycolipid
contamin
could
exclud
howev
signific
amount
label
incorpor
glycoprotein
proteolyt
cleavag
product
therefor
appear
contain
coval
bound
fatti
acid
differ
label
characterist
glycoprotein
el
confirm
sugar
constitu
analys
el
glycopeptid
obtain
purifi
polypeptid
digest
pronas
gel
filtrat
biogel
el
glycopeptid
fraction
chromatographi
wheat
germ
agglutinin
bound
sepharos
unbound
fraction
appli
materi
bound
fraction
elut
l
mnacetylglucosamin
major
sugar
constitu
bound
unbound
fraction
galactos
nacetylglucosamin
nacetylgalactosamin
neuramin
acid
fig
tabl
latter
sugar
identifi
highvoltag
paper
electrophoresi
neuraminidasetr
el
glycopeptid
fig
pg
total
sugar
hydrolyz
reduc
peracetyl
analyz
fuse
silica
capillari
column
combin
ga
chromatographymass
spectrometri
temperatur
program
degcmin
appli
min
delay
start
temperatur
peak
identifi
accord
retent
time
abscissa
fragment
pattern
peak
scan
number
show
sugar
characterist
fragment
glycopeptid
appli
biogel
column
cm
x
cm
elut
water
contain
wv
nan
shade
profil
fraction
ml
taken
radioact
portion
determin
liquid
scintil
count
glycopeptid
elut
molecular
weight
enzymat
remov
neuramin
acid
residu
reduct
molecular
weight
observ
main
fraction
open
profil
label
elut
posit
free
nacetylneuramin
acid
fraction
materi
lyophil
comigr
nacetylneuramin
acid
standard
highvoltag
paper
electrophoresi
fraction
contain
neglig
amount
mannos
fucos
presenc
minut
amount
glucos
consid
contamin
sinc
radioact
glucos
detect
hydrolys
galactoselabel
glycopeptid
paper
chromatographi
due
metabol
convers
radioact
nacetylgalactosamin
detect
method
hydrolys
el
glycopeptid
label
either
galactos
data
shown
wheat
germ
agglutininbound
unbound
fraction
resist
treatment
endo
galactosidas
escherichia
freundii
enzym
hydrolyz
linkag
polylactosaminyl
structur
allow
branch
galactos
residu
fukuda
sugar
composit
glycopeptid
show
typic
composit
nglycosid
link
carbohydr
sidechain
commonli
found
viral
glycoprotein
treatment
glucosaminelabel
glycopeptid
endonacetylglucosaminidas
h
streptomye
griseu
follow
analysi
biogel
minu
mesh
column
reveal
materi
sensit
enzym
indic
presenc
mannoserich
sidechain
evidenc
bind
studi
glycopeptid
column
concanavalin
coval
link
sepharos
glucosaminelabel
glycopeptid
bind
elut
buffer
could
elut
mmamethylmannosid
show
high
affin
lectin
elut
mmcumethylmannosid
data
shown
standard
procedur
distinguish
nglycosid
carbohydrateprotein
linkag
oglycosid
linkag
suscept
latter
mild
alkalin
degrad
zinn
et
al
appli
method
sugarlabel
glycoprotein
el
analyz
releas
oligosaccharid
passag
dowex
w
x
h
form
highvoltag
paper
electrophoresi
gel
filtrat
ion
carbohydr
label
el
recov
runthrough
ionexchang
column
wherea
essenti
label
retain
highvoltag
paper
electrophoresi
ph
elderiv
oligosaccharid
charg
migrat
toward
anod
el
label
amino
acid
use
similar
pelimin
reaction
subject
electrophoresi
without
prior
ionexchang
treatment
label
remain
origin
indicab
alkalin
condit
eliminat
ion
reaction
signific
breakdown
polypeptid
backbon
el
occur
oligosaccharid
releas
galactoselabel
el
resolv
gel
filt
ration
calibr
biogel
column
four
differ
peak
elut
fraction
fig
use
oligosaccharid
mannoserich
type
standard
molecular
weight
determin
respect
structur
analysi
fraction
investig
mucinetyp
glycoprotein
contain
exclusivelg
oglycosid
carbohydr
sidechain
link
serin
hreonin
residu
shown
hat
amino
acid
convert
alanin
naminobutyr
acid
rrspect
ive
pelimin
follow
palladiumcatalyz
hjdrogen
pigman
down
use
porcin
submaxillari
mucin
abl
confirm
convers
howev
carri
amino
acid
analys
el
subject
pelimin
reduc
condit
unabl
detect
decreas
serin
threonin
content
fraction
number
fro
molecular
weight
oligosaccharid
obtain
pelimin
el
coronaviru
glycoprotein
el
subject
ielimin
releas
oligosaccharid
analyz
biogel
minu
mesh
column
cm
x
cm
fraction
ml
taken
assay
radioact
follow
compound
use
calibr
column
indic
arrow
vc
exclus
volum
bovin
serum
albumin
glycoprotein
concomit
increas
alanin
aaminobutyr
acid
content
failur
identifi
serin
threonin
attach
site
oligosaccharid
could
explain
fact
small
proport
residu
glycosyl
also
conceiv
reduc
solubl
carbohydratefre
el
k
holm
person
commun
allow
proper
hydrogen
unsatur
amino
acid
form
pelimin
intracellular
synthesi
viral
polypeptid
shown
figur
infect
cell
pulsechas
label
hour
post
infect
cytoplasm
lysat
immunoprecipit
serum
rais
purifi
viru
three
major
virusspecif
protein
precipit
form
singl
band
doubl
band
az
comigr
data
shown
virion
protein
n
el
addit
four
minor
speci
precipit
valu
speci
appear
leucin
label
minut
chase
comigr
virion
v
indic
prot
eolyt
cleavag
lllr
speci
posttransl
event
two
intracellular
form
el
protein
also
report
murin
coronaviru
jhm
suggest
siddel
et
nl
larger
speci
deriv
glpcosyl
smaller
romept
type
precursorproduct
relationship
exist
x
speci
el
coronaviru
suggest
observ
smaller
form
alreadi
label
short
puls
wherea
larger
appear
longer
chase
shown
carbohydr
moieti
glycoprotein
el
could
label
wit
h
radioact
galactos
glucosamin
roth
sugar
incorpor
ill
speci
el
polvpeptid
nr
speci
pulsechas
label
esperi
fig
track
r
suggest
glyoxyl
el
likt
l
rotrolyt
cleavag
posttranslat
ional
event
f
ffmt
glycotyl
inhibitor
synthesi
el
clnd
el
tunicamycin
inhibit
format
dolichollink
saet
lglucosariri
pyrophosphat
e
serv
essenti
int
ermediat
e
sglycosvl
glvcoprotein
review
see
schwarz
datema
effect
inhibitor
synthesi
viral
glycoprotein
infect
cell
also
shown
figur
unicamycin
concentr
pgml
prot
ein
synthesi
slightli
redm
furthermor
glycosyl
el
follow
essenti
kinet
absenc
inhibitor
howev
show
drastic
decreas
appar
molecular
weight
yield
speci
design
similar
experi
speci
could
label
wit
h
galactos
dat
shown
indic
iwr
speci
nonglycosql
form
ed
inhibitori
effect
tunicamycin
synthesi
also
repot
holm
et
nl
howev
author
unabl
demonstr
synthesi
nonglycosyl
analog
presenc
tunicamycin
inhibitor
pdroxi
arabinohexos
known
int
erferr
format
xglycosid
linkag
inhibit
viru
particl
format
demonstr
figur
show
glycoprotein
purifi
viru
particl
form
presenc
inhibitor
compound
interf
glycosyl
signific
effect
el
particl
form
presenc
tunicamycin
lack
detect
amount
caus
hetjerogen
probabl
due
glycosyl
vin
altern
pathway
shorter
oligosaccharid
transfer
lipidlink
intermedi
nascent
polypept
ide
process
way
outlin
int
roduct
datema
et
specif
infect
viru
particl
synthes
presenc
inhibitor
determin
plaqu
assay
tunicamycin
well
glucos
reduc
infect
factor
indic
hat
gtycosyl
essenti
requir
infect
coronaviru
particl
calbiochem
serva
tunicamycin
eli
lilli
present
concentr
mgml
mgml
pgml
respect
infect
particl
releas
cultur
fluid
determin
plaqu
assay
titer
x
pfuml
control
viru
x
pfuml
fluoroglucos
x
pfuml
deoxyglucos
x
io
pfuml
tunicamycin
purifi
viru
prepar
analyz
cylindr
sdslo
wv
polgacrylamid
gel
slice
count
describ
materi
method
data
demonstr
two
glycoprotein
speci
coronaviru
envelop
differ
sever
import
structur
biosynthet
properti
includ
structur
carbohydr
sidechain
coval
bind
fatti
acid
process
step
cotransl
posttransl
level
sensit
glycosyl
inhibitor
differ
calear
el
belong
two
distinct
glycoprotein
class
glycoprotein
carbohydr
sidechain
nglycosid
linkag
case
glycoprotein
rhabdovirus
orthoand
paramyxovirus
alphavirus
oncornavirus
conclus
base
follow
observ
show
metabol
label
chemic
analysi
contain
glucosamin
mannos
galactos
fucos
neuramin
acid
basic
carbohydr
composit
found
glycoprotein
virus
sidechain
complex
type
glycopeptid
deriv
sensit
treatment
endoglycosidas
h
show
strong
bind
concanavalin
indic
hat
sidechain
belong
mannoserich
type
sidechain
remov
elimin
glycosyl
inhibit
tunicamycin
alter
compound
interfer
specif
biosynthesi
oligosaccharid
link
sglycosid
linkag
polypeptid
presenc
tunicamycin
svnthesiz
nonglycosyl
form
polypeptid
appear
quit
stabl
infect
cell
avail
evid
indic
incorpor
viru
particl
accord
data
present
similar
studi
sturman
still
form
conditjion
observ
unglycosyl
polypeptid
detect
presenc
inhibitor
glycosyl
indic
glycosyl
glycoprotein
initi
cotransl
level
typic
nglycosid
carbohydr
protein
linkag
yet
aspecu
resembl
viral
glycoprotein
wellestablish
nglycosid
linkag
g
protein
vesicular
stomat
viru
glycoprotein
el
alphavirus
hemagglutinin
influenza
viru
f
protein
paramyxovirus
acyl
schmidt
found
coronaviru
protein
contain
also
fatti
acid
cdoval
linkag
posttransl
proteolyt
cleavag
anoth
modificat
ion
observ
coronavirus
whole
seri
viral
glycoprotein
eg
influenza
viru
hemagglutinin
f
hn
glp
oprotein
paramyxovirus
precursor
glycoprotein
lphavirus
envelop
glycoprotein
type
c
retrovirus
review
see
klenk
cc
bott
coronaviru
jhm
author
also
propos
glycosyl
event
explain
chang
appar
molecular
weight
presenc
tunicamycin
glycosyl
complet
inhibit
nonglycosyl
el
p
recess
glycosyl
speci
kinet
absenc
antibiot
also
interfer
nglycosyl
effect
glycosyl
el
light
investig
report
gahmberg
et
al
observat
ion
support
concept
oglycosid
linkag
el
author
studi
effect
tunicamycin
glycosyl
glycophorin
contain
n
oglycosid
sidechain
found
drug
int
erfer
attach
nglycosid
sidechain
effect
oglycosid
linkag
interest
see
structur
differ
el
correl
differ
function
two
glycoprotein
evid
ed
necessari
cellfus
capac
viru
holm
ef
nl
proteolyt
cleavag
essenti
activ
storz
et
al
therefor
tempt
specul
initi
infect
glycoprotein
orthoand
paramyxovirus
glycoprotein
e
hand
suggest
play
import
role
envelop
format
interact
envelop
nucleocapsid
sturman
et
al
respect
interest
note
contrast
envelop
virus
coronavirus
matur
bud
endoplasm
reticulum
mcintosh
whether
unusu
carbohydr
pattern
el
correl
unusu
bud
site
remain
seen
despit
fact
larg
varieti
secretori
membran
protein
great
biolog
interest
glycoprotein
oglycosid
linkag
review
see
montreuil
int
racellular
transport
process
glycoprotein
still
poorli
understood
know
two
report
evid
exist
oglycosid
linkag
viral
glycoprotein
obtain
glycoprotein
hemagglutinin
vaccinia
viru
found
infect
cell
viru
particl
shida
dale
lssl
herp
simplex
viru
glycoprotein
olofsson
et
al
elfried
otto
mechthild
rose
grate
acknowledg
grate
r
rott
valuabl
discuss
k
v
holm
l
st
urman
int
roduc
us
coronaviru
system
commun
result
work
heforr
public
work
support
deutsch
forschungsgemeinschaft
sfb
virolopia
